|
| Press Releases |
|
 |
|
| Thursday, March 17, 2022 |
|
|
华领医药公布2021年全年业绩 |
| 华领医药（「公司」，香港联交所股份代号：2552），今天宣布公司及其附属公司截至2021年12月31日止，经审核的全年业绩（「报告期」）。 more info >> |
|
|
華領醫藥公佈2021年全年業績 |
| 華領醫藥（「公司」，香港聯交所股份代號：2552），今天宣佈公司及其附屬公司截至2021年12月31日止，經審核的全年業績（「報告期」）。 more info >> |
|
| Friday, October 25, 2024 |
|
|
Founder of Hua Medicine Dr. Chen Li was awarded the 'C.C. Tan Life Science Industrialization Award' |
| The 17th C.C. Tan Life Science Award ceremony was held at Shenyang Pharmaceutical University on October 9th. Dr. Chen Li, Founder and Chief Executive Officer of Hua Medicine, was awarded the C.C. Tan Life Science Industrialization Award . more info >> |
|
| Friday, August 30, 2024 |
|
|
Hua Medicine Announces 2024 Interim Results |
| Hua Medicine (the "Company", HKEx: 2552) today announces the unaudited consolidated results of the Company and its subsidiaries for the six months ended June 30, 2024 (the "Reporting Period"), and the Company's business progress for the first half of the year and business outlook. more info >> |
|
|
華領醫藥公佈2024年中期業績 |
| 全球首創新藥雙功能葡萄糖激酶激活劑（GKA）多格列艾汀（商品名：華堂寧®）于2023年底成功納入《國家基本醫療保險、工傷保險和生育保險藥品目錄》（“國家醫保藥品目錄”）。華領醫藥與商業化合作夥伴拜耳以及80家一級經銷商共同推動多格列艾汀的商業化，開始進入中國31個省級醫藥市場。 more info >> |
|
|
华领医药公布2024年中期业绩 |
| 华领医药（“公司”，香港联交所股份代号：2552）宣布公司及其附属公司截至2024年6月30日止，6个月（“报告期”）未经审核的综合业绩，以及公司上半年业务进展和未来业务展望。 more info >> |
|
| Friday, August 25, 2023 |
|
|
华领医药公布2023年中期业绩 |
| -- 全球首创新药葡萄糖激酶激活剂（GKA）多格列艾汀（商品名：华堂宁®）于2022年9月在中国获批上市。 more info >> |
|
|
華領醫藥公佈2023年中期業績 |
| -- 全球首創新藥葡萄糖激酶激活劑（GKA）多格列艾汀（商品名：華堂寧®）於2022年9月在中國獲批上市。 more info >> |
|
|
Hua Medicine Announces 2023 Interim Results |
| First-in-class glucokinase activator (GKA) HuaTangNing (dorzagliatin) was approved in China in September 2022. more info >> |
|
| Monday, October 10, 2022 |
|
|
华领医药全球首创新药葡萄糖激酶激活剂华堂宁(R)获批上市 有望拓展中国2型糖尿病治疗新格局 |
| 华领医药（「公司」，香港联交所股份代号：2552.HK）今天宣布，公司研发的全球首创（first-in-class）新药葡萄糖激酶激活剂（GKA）华堂宁®（多格列艾汀片，dorzagliatin，HMS5552）已于10月8日获得中国国家药品监督管理局（NMPA）的上市批准。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
'The Charm of Chunhyang Captivates the World' 96th Namwon Chunhyang Festiva Kicks Off on April 30
Apr 11, 2026 19:50: JST
|
|
|
'The Charm of Chunhyang Captivates the World' 96th Namwon Chunhyang Festiva Kicks Off on April 30
Apr 11, 2026 18:50 HKT/SGT
|
|
|
AIONOS Highlights Enterprise AI Vision for APAC at GITEX AI ASIA 2026
Apr 10, 2026 22:43: JST
|
|
|
AIONOS Highlights Enterprise AI Vision for APAC at GITEX AI ASIA 2026
Apr 10, 2026 20:00 HKT/SGT
|
|
|
FinHarbor Repackages Its Hybrid Neobank Module - A Unified Banking and CEX Infrastructure Stack for Crypto-Native Financial Products
Apr 10, 2026 18:00: JST
|
|
|
FinHarbor Repackages Its Hybrid Neobank Module - A Unified Banking and CEX Infrastructure Stack for Crypto-Native Financial Products
Apr 10, 2026 17:00 HKT/SGT
|
|
|
Matthias "The Greenman" Gelber Receives FAMAS Prestige Excellence Award; Set to Headline Global CSR & ESG Summit 2026
Apr 10, 2026 16:00 HKT/SGT
|
|
|
TOYOTA、ノアならびにヴォクシーを一部改良
Apr 10, 2026 13:30: JST
|
|
|
Luxury NEV Leader Seres Posts Record RMB164.89B Revenue in 2025, Proposes RMB1.9B Dividend
Apr 10, 2026 11:57: JST
|
|
|
Honda、小型EV「Super-ONE」の先行予約を開始
Apr 10, 2026 11:10: JST
|
|
|
Hondaの電動モーターサイクル「Honda WN7」、モビリティロボット「UNI-ONE」が2026年レッド・ドット・デザイン賞 プロダクトデザイン部門において最高賞「ベスト・オブ・ザ・ベスト賞」を受賞
Apr 10, 2026 11:10: JST
|
|
|
Luxury NEV Leader Seres Posts Record RMB164.89B Revenue in 2025, Proposes RMB1.9B Dividend
Apr 10, 2026 10:57 HKT/SGT
|
|
|
豪华新能源车企赛力斯2025年高端战略成效显著 问界比肩奔驰宝马
Apr 10, 2026 10:14 HKT/SGT
|
|
|
豪華新能源車企賽力斯2025年高端戰略成效顯著 問界比肩奔馳寶馬
Apr 10, 2026 10:08 HKT/SGT
|
|
|
IFS and NEC to Deploy Next-Generation Core System IFS Cloud for Hoshizaki
Apr 10, 2026 10:10 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
